Xolair Information:
Buy Xolair
Xolair (Omalizumab) is used to treat moderate-to-severe persistent asthma in adults who have a positive allergy test to a year-round airborne allergen and whose symptoms aren't well managed with inhaled corticosteroids. It is also used to treat chronic idiopathic urticaria (CIU) in patients unresponsive to treatment with antihistamines. It may also be used in the treatment of nasal polyps in adults whose symptoms are inadequately controlled with nasal corticosteroids. Furthermore, it is also used to reduce allergic reactions from accidental exposure to foods in patients aged one year and older with IgE-mediated food allergies. Xolair, containing the active ingredient omalizumab, is a monoclonal antibody classified as an anti-IgE medication. Xolair works by binding to immunoglobulin E (IgE) antibodies, which are responsible for allergic reactions. By blocking IgE from attaching to receptors on mast cells and basophils, it reduces the release of histamine and other inflammatory substances that cause allergy symptoms, thus helping to control asthma, alleviate chronic urticaria symptoms, and shrink nasal polyps. It is worth noting that this medication should not be used for the emergency treatment of any allergic reactions, including anaphylaxis and acute exacerbation of asthma.
Generic Xolair from Canada
Canada Drugs Online proudly serves you the brand Xolair Prefilled Syringe, manufactured by Novartis from Canada (Local Pick Up Only). The generic Xolair is currently not available. Please call us toll-free at 1-877-900-3784 for details.
CanadaDrugsOnline.com also carries other medications for
Asthma/respiratory disorders, such as
Dulera and
Symbicort turbuhaler.
CanadaDrugsOnline.com supplies only genuine Xolair from Canada shipped using the Canadian packaging. This Xolair is manufactured by Genetech Inc. (collaboration with Novartis), the worldwide manufacturer of Xolair. This offer is neither endorsed nor authorized by Genetech Inc. (the United States and Canadian distributor of Xolair). CanadaDrugsOnline.com has no affiliation whatsoever with Genetech Inc.
Xolair Side Effects:
This medicine may cause some mild side effects, including dizziness, earache, headache, sore throat, common cold symptoms, redness of the skin, pain in the joints, legs, or arms, pain, itching, swelling, or redness near the injection site, and tiredness. Contact your doctor if these mild side effects persist or worsen.
Rare but possibly serious side effects of this medication include persistent fever and joint pain, cancer, chest pain, shortness of breath, numbness or feeling pins and needles in the arms or legs, nausea or vomiting, abdominal pain, racing heart, persistent cough, severe body itching, rash, swelling of your face, lips, tongue, or throat, and extreme dizziness. If you observe these severe side effects, discontinue this medication and seek immediate medical attention. Additionally, inform your doctor about any other side effects not listed here.
Omalizumab (Xolair®) has been shown in clinical trials to reduce the risk of exacerbations, hospitalizations, and ER visits in patients with moderate to severe allergic asthma. It is also well tolerated with a good safety profile, especially when used under the supervision of a qualified healthcare professional.
Xolair Directions:
Xolair is available in pre-filled syringes and should be administered as a subcutaneous injection in the upper arm or front and middle of thighs. The injection should be rotated for each new injection at least 1 inch from the area used for the last injection. It is typically given every 2-4 weeks, depending on the condition being treated. Your doctor will determine the appropriate dose of this medication for you. A qualified healthcare professional best administers this medicine. However, have your doctor or pharmacist show you how to administer this medication if you are going to inject yourself. Also, check out the leaflet in the medication pack for more details on usage. Store this medication in a refrigerator (2⁰C- 8⁰C); do not freeze.
Xolair Precautions:
Before using this medication, it is essential to inform your doctor about any previous or current medical conditions you may have, especially the following:
• Allergic reaction to omalizumab, other ingredients of this medication, or any other medicine;
• Cancer;
• Parasitic infection
Consult your doctor before using this medication, as appropriate blood tests may need to be done before the commencement of this medication to determine the proper dose and dosing frequency. Consult your doctor before using this medication during pregnancy or while breastfeeding. This medication is not recommended for use in children younger than one year. Some medicines may interact with omalizumab, affecting the way it works in the body. Therefore, make sure you inform your doctor about all the medications, including herbal medicines and supplements you are taking, before using Xolair to prevent drug interactions.
The content on this page has been supplied to canadadrugsonline.com by an independent third party contracted to provide information for our website. CanadaDrugsOnline relies on these third parties to create and maintain this information and cannot guarantee the medical efficacy, accuracy or reliability of the information that has been provided to us. If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a health professional. Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy. We affiliate with other dispensaries that ship product to our customers from the following jurisdictions: Canada, Singapore, New Zealand, Turkey, Mauritius, India, and United Kingdom. The items in your order maybe shipped from any of the above jurisdictions. The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with our authorized dispensaries that procure product through reliable sources. All prices are in US dollars.